Neurocrine Biosciences, Inc. to Ring The NASDAQ Stock Market Opening Bell

ADVISORY, June 7, 2011 (GLOBE NEWSWIRE) -- What: Neurocrine Biosciences (NBIX), a biopharmaceutical company focused on neurological and endocrine diseases and disorders, will visit the NASDAQ MarketSite in New York City's Times Square.